Novartis Net Income 2024

Novartis Net Income

13.89 B USD

Novartis Dividend yield

3.3 %

Ticker

NOVN.SW

ISIN

CH0012005267

WKN

904278

In 2024, Novartis's profit amounted to 13.89 B USD, a -6.47% increase from the 14.85 B USD profit recorded in the previous year.

The Novartis Net Income history

YEARNET INCOME (undefined USD)
2029e15.69
2028e15.59
2027e15.82
2026e16.54
2025e15.29
2024e13.89
202314.85
20226.96
202124.02
20208.07
201911.73
201812.61
20177.7
20166.71
201517.78
201410.21
20139.18
20129.51
20119.11
20109.79
20098.4
20088.2
200711.95
20067.18
20056.13
20045.77

Novartis Aktienanalyse

What does Novartis do?

Novartis AG is a globally active company operating in the pharmaceutical, ophthalmology, and generics manufacturing sectors. The company, headquartered in Basel, Switzerland, was founded in 1996 and originated from a merger between Ciba-Geigy and Sandoz. Novartis AG is now a leading company worldwide in the research, development, production, and marketing of pharmaceuticals and other health products. Novartis ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Novartis's Profit Margins

The profit margins of Novartis represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Novartis's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Novartis's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Novartis's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Novartis’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Novartis Stock

How much profit has Novartis made this year?

Novartis has made 13.89 B USD this year.

How has the profit developed compared to last year?

The profit has increased by -6.47% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Novartis publish its earnings?

Novartis publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Novartis?

The profits of Novartis are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Novartis?

You can learn more about the earnings of Novartis by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Novartis pay?

Over the past 12 months, Novartis paid a dividend of 3.2 USD . This corresponds to a dividend yield of about 3.3 %. For the coming 12 months, Novartis is expected to pay a dividend of 3.28 USD.

What is the dividend yield of Novartis?

The current dividend yield of Novartis is 3.3 %.

When does Novartis pay dividends?

Novartis pays a quarterly dividend. This is distributed in the months of April, April, April, April.

How secure is the dividend of Novartis?

Novartis paid dividends every year for the past 26 years.

What is the dividend of Novartis?

For the upcoming 12 months, dividends amounting to 3.28 USD are expected. This corresponds to a dividend yield of 3.39 %.

In which sector is Novartis located?

Novartis is assigned to the 'Health' sector.

Wann musste ich die Aktien von Novartis kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Novartis from 3/11/2024 amounting to 3.3 USD, you needed to have the stock in your portfolio before the ex-date on 3/7/2024.

When did Novartis pay the last dividend?

The last dividend was paid out on 3/11/2024.

What was the dividend of Novartis in the year 2023?

In the year 2023, Novartis distributed 3.1 USD as dividends.

In which currency does Novartis pay out the dividend?

The dividends of Novartis are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Novartis stock can be added to a savings plan with the following providers: ING

Andere Kennzahlen von Novartis

Our stock analysis for Novartis Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Novartis Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.